对旨在优化高血压并发性疾病中药物坚持的干预措施进行范围审查
Adwoa Oforiwaa Kwakye1, Araba Atta Hutton-Nyameaye2, Constance Caroline Cobbold3
1Department of Pharmacy Practice and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, University of Ghana, P. O. Box LG 43, Legon, Ghana.
Research in social & administrative pharmacy : RSAP
|January 16, 2025
概括
在患有并发性疾病的高血压患者中,改善药物坚持是至关重要的. 患者教育和简化疗法等干预措施显著提高了患者的坚持和临床结果,尽管长期影响需要进一步研究.
科学领域:
- 药理学和临床药学 药理学和临床药学
- 公共卫生和流行病学
- 心血管医学 心血管医学
背景情况:
- 患有并发病的高血压患者的药物不服药会对健康结果产生负面影响.
- 现有的提高坚持度的策略需要综合证据来进行临床应用.
- 高血压并发症对持续使用药物提出了独特的挑战.
研究的目的:
- 系统地审查旨在改善高血压患者同时存在疾病的药物坚持的干预措施.
- 综合各种增强坚持的策略有效性的证据.
- 为了更好的患者管理,为临床决策提供信息.
主要方法:
- 使用CINAHL,Cochrane Trials,MEDLINE和SCOPUS数据库进行了全面的范围审查,并使用Google Scholar进行了补充.
- 搜索是在2023年9月至2024年2月期间进行的,遵循PRISMA-SCR指南.
- 分析了来自456项独特研究的26篇精选论文,分析了干预措施,人群和坚持措施.
主要成果:
- 多模式干预方法,通常由药剂师提供,是普遍存在的 (25项研究).
- 干预措施在80% (22项研究) 的审查文献中显著改善了药物坚持.
- 在16项研究中,患者教育成为与改善守和血压控制相关的关键组成部分.
结论:
- 患者教育,简化治疗计划和多学科护理是提高药物坚持和临床结果的有效策略.
- 这些干预措施对伴随性疾病患者的高血压管理有前途.
- 需要进一步的研究来阐明这些干预措施的长期有效性和影响.
相关概念视频
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
3
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
3
01:23Hypertension V: Nursing management
2
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
2
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:30Heart Failure V: Medical Management
2
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
01:22Heart Failure VI: Adjunct Therapies
5
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5